Perrigo Company plc $PRGO Shares Bought by Victory Capital Management Inc.

Victory Capital Management Inc. grew its position in Perrigo Company plc (NYSE:PRGOFree Report) by 5.4% during the third quarter, Holdings Channel reports. The firm owned 1,546,256 shares of the company’s stock after acquiring an additional 79,213 shares during the period. Victory Capital Management Inc.’s holdings in Perrigo were worth $34,435,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of PRGO. Elo Mutual Pension Insurance Co boosted its position in Perrigo by 10.8% in the third quarter. Elo Mutual Pension Insurance Co now owns 28,717 shares of the company’s stock valued at $640,000 after buying an additional 2,805 shares during the last quarter. Bahl & Gaynor Inc. raised its position in Perrigo by 5.4% during the 3rd quarter. Bahl & Gaynor Inc. now owns 2,087,075 shares of the company’s stock worth $46,479,000 after buying an additional 107,774 shares during the last quarter. Rafferty Asset Management LLC lifted its stake in Perrigo by 9.7% during the 3rd quarter. Rafferty Asset Management LLC now owns 12,153 shares of the company’s stock valued at $271,000 after acquiring an additional 1,071 shares during the period. Huntington National Bank lifted its stake in Perrigo by 125.0% during the 3rd quarter. Huntington National Bank now owns 2,372 shares of the company’s stock valued at $53,000 after acquiring an additional 1,318 shares during the period. Finally, Citigroup Inc. boosted its holdings in shares of Perrigo by 110.6% in the 3rd quarter. Citigroup Inc. now owns 89,197 shares of the company’s stock valued at $1,986,000 after acquiring an additional 46,848 shares during the last quarter. Institutional investors and hedge funds own 95.91% of the company’s stock.

Analyst Ratings Changes

PRGO has been the subject of several recent research reports. Argus raised shares of Perrigo to a “hold” rating in a report on Wednesday, January 14th. Zacks Research raised Perrigo from a “strong sell” rating to a “hold” rating in a research report on Friday, February 13th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Perrigo in a research note on Monday, December 22nd. Jefferies Financial Group reissued a “hold” rating on shares of Perrigo in a report on Thursday, February 26th. Finally, JPMorgan Chase & Co. lowered their target price on Perrigo from $20.00 to $18.00 and set a “neutral” rating on the stock in a research note on Monday, December 15th. One research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Perrigo currently has a consensus rating of “Hold” and an average price target of $19.33.

Read Our Latest Stock Analysis on Perrigo

Perrigo Stock Performance

Shares of NYSE PRGO opened at $10.75 on Monday. The company has a market capitalization of $1.48 billion, a PE ratio of -1.05, a price-to-earnings-growth ratio of 1.29 and a beta of 0.41. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.63 and a current ratio of 2.76. The company’s fifty day moving average price is $14.19 and its 200 day moving average price is $16.99. Perrigo Company plc has a 1 year low of $10.65 and a 1 year high of $29.08.

Perrigo (NYSE:PRGOGet Free Report) last released its quarterly earnings data on Thursday, February 26th. The company reported $0.77 earnings per share for the quarter, missing analysts’ consensus estimates of $0.80 by ($0.03). The firm had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.09 billion. Perrigo had a negative net margin of 33.51% and a positive return on equity of 9.41%. The firm’s quarterly revenue was down 2.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.93 EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, research analysts predict that Perrigo Company plc will post 2.56 earnings per share for the current year.

Perrigo Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 24th. Shareholders of record on Monday, March 2nd will be given a dividend of $0.29 per share. The ex-dividend date is Monday, March 2nd. This represents a $1.16 dividend on an annualized basis and a yield of 10.8%. Perrigo’s dividend payout ratio is currently -11.28%.

Perrigo Company Profile

(Free Report)

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.

Recommended Stories

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGOFree Report).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.